Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102986 · ClinicalTrials.gov registry record · NA
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT00102986 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 116 participants.
The verdict
NCT00102986, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
Men's and women's bodies may process anti-HIV drugs differently. The purpose of this study is to determine the differences in blood levels of soft gel capsules and tablets of lopinavir/ritonavir (LPV/r) in HIV infected men and women.
Interventions
- DRUG Lopinavir/ritonavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00102986
The ClinicalTrials.gov registry entry for NCT00102986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lopinavir/ritonavir is the first listed.
NCT00102986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00102986 about?
NCT00102986 is a clinical study titled "Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women". Men's and women's bodies may process anti-HIV drugs differently. The purpose of this study is to determine the differences in blood levels of soft gel capsules and tablets of lopinavir/ritonavir (LPV/r) in HIV infected men and women.
What is the current status of trial NCT00102986?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2005-10. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00102986?
The interventions under investigation include: Lopinavir/ritonavir (DRUG).
Who is sponsoring clinical trial NCT00102986?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.